Related Experiment Videos
HIV protease: enzyme function and drug resistance.
S Gulnik1, J W Erickson, D Xie
1SAIC Frederick, National Cancer Institute, Frederick Cancer Research and Development Center, Maryland 21702-1201, USA.
Vitamins and Hormones
|February 11, 2000
Summary
This review covers HIV protease, essential for viral maturation and a key target for AIDS therapies. It discusses enzyme properties and drug resistance mechanisms in HIV protease mutants.
Area of Science:
- Biochemistry
- Virology
- Drug Discovery
Background:
- Human Immunodeficiency Virus (HIV) protease is crucial for viral maturation.
- Its enzymatic activity is essential for HIV infectivity.
- HIV protease is a primary therapeutic target for Acquired Immunodeficiency Syndrome (AIDS) treatment.
Purpose of the Study:
- To review the biochemical and biophysical properties of HIV protease.
- To discuss clinical and in vitro observations of resistance to protease inhibitors.
- To explore drug resistance mechanisms in HIV protease mutants.
Main Methods:
- Literature review of biochemical and biophysical studies.
- Analysis of clinical data on protease inhibitor resistance.
- Examination of in vitro studies on HIV protease mutants.
Main Results:
- HIV protease's essential role in gag and gag-pol polyprotein processing.
- Identification of HIV protease as a critical target for AIDS therapeutics.
- Insights into the mechanisms of drug resistance developed by HIV protease mutants.
Conclusions:
- Understanding HIV protease properties is vital for developing effective AIDS treatments.
- Drug resistance mechanisms in HIV protease mutants necessitate ongoing research.
- Continued investigation into protease inhibitors and resistance is crucial for long-term HIV management.